Company intelligence / Profile preview

Tunnel Vision

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Tunnel (Tunnel.bio) is a computational biology company focused on building a platform for protein engineering and design. The company leverages advanced machine learning and structural biology to design novel proteins with specific therapeutic functions. By integrating computational modeling with experimental validation, Tunnel aims to accelerate the discovery of next-generation biologics. Their platform is designed to address complex challenges in protein stability, binding affinity, and specificity, particularly for targets that are difficult to address with traditional methods.

Modalities: ProteinPeptides
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Tunnel Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tunnel Vision.

Explore the full profile